Insight Molecular Diagnostics Inc. (IMDX) financials · rev $4.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Insight Molecular Diagnostics Inc. (IMDX) rev $4.1M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $4.05M | $1.88M |
| Cost of Revenue | $1.75M | N/A |
| Gross Profit | $2.30M | $740.0K |
| Operating Income | -$51.1M | -$61.0M |
| Net Income | -$50.2M | -$60.7M |
| EPS (Diluted) | -$1.65 | -$4.66 |
Cost of Revenue N/A — Withheld: stored cost of revenue does not reconcile with revenue and gross profit for this period.
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $25.8M | $35.1M |
| Current Assets | $15.3M | $11.8M |
| Cash & Equivalents | $11.6M | $8.64M |
| Inventory | $446.0K | $410.0K |
| PP&E | $9.25M | $5.98M |
| Total Liabilities | $57.2M | $47.4M |
| Current Liabilities | $12.1M | $7.28M |
| Shareholders' Equity | -$31.5M | -$12.3M |
| Retained Earnings | -$400.8M | -$350.5M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$22.2M | -$20.7M |
| CapEx | $3.19M | $516.0K |
| Investing Cash Flow | -$3.19M | -$512.0K |
| Financing Cash Flow | $28.1M | $20.4M |
| Net Change in Cash | $2.58M | -$796.0K |
| Free Cash Flow | -$25.4M | -$21.2M |
FAQ
What is IMDX P/E and revenue?
Insight Molecular Diagnostics Inc. (IMDX) rev $4.1M.
What is IMDX revenue?
Insight Molecular Diagnostics Inc. last cached revenue is $4.05M (FY2025).
Is IMDX profitable?
Insight Molecular Diagnostics Inc. last cached net income is -$50.2M (FY2025).
What are IMDX total assets?
Insight Molecular Diagnostics Inc. last cached total assets are $25.8M (FY2025).
What is IMDX free cash flow?
Insight Molecular Diagnostics Inc. last cached free cash flow is -$25.4M (FY2025).
Not investment advice. Cached statements, not a live tape.